ArticleDrug design, development and therapy2025
Investigating Remedial Strategies for Missed or Delayed Dose of Sertraline in Chinese Adolescent Patients with Depressive Disorders via Population Pharmacokinetics Modeling and Simulation Approaches.
Article in Drug design, development and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comparative Analysis of Prescriptions and Pharmacy Services in Internet-Based Psychiatric Hospital During and After the COVID-19 Pandemic: Retrospective Cross-Sectional Observational Study.Journal of medical Internet research · 2026Observational
- Genetic variability and response to sertraline in pediatric populations: a review on pharmacogenetics, pharmacokinetics, and the risk of adverse events.Frontiers in child and adolescent psychiatry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sertraline is a commonly used medication for adolescent patients with depression, and missed or delayed dose has been frequently observed during long-term treatment. However, little is known about the remedial strategies for missed or delayed dose of sertraline. Hence, we designed the remedial strategies of different missed dosage scenarios based on population pharmacokinetics (PPK) model simulation, aiming to provide medication guidance to Chinese adolescent depressive patients. Methods: A total of 221 sertraline concentration monitoring data were collected from 103 sertraline-treated adolescent patients with depression. Data analysis was performed using nonlinear mixed-effects model, and situations of different missed doses were simulated in the sertraline PPK model, including one single missed dose and double/triple missed doses under different therapeutic dosages. Results: A one-compartment model without covariates was established to characterize the PPK of sertraline in adolescent patients with depression. Population typical values of sertraline clearance and apparent distribution volume were 65.8 L/h and 1570 L, respectively. Our simulation results revealed that when adolescent patients missed or delayed sertraline administration, the scheduled dose should be administered immediately. Additionally, our results suggested that the dose of the next remedial time should be adjusted according to the duration of the delay and the frequency of missed doses. Conclusion: In this study, we developed remedy strategies for missed or delayed dosing of sertraline in Chinese adolescents with depression based on our PPK model simulations. These findings may provide valuable clinical guidance for sertraline treatment in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.